Effect of Endothelium on Diabetes‐Induced Changes in Constrictor Responses Mediated by 5‐Hydroxytryptamine in Rat Aorta

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  1993-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1097/00005344-199309000-00012PMID 7504133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A MODIFICATION OF RECEPTOR THEORY

  1997cited by this paper
• Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction

  1992cited by this paper
• Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin‐1 of aortic rings from streptozotocin‐induced diabetic rats

  1992cited by this paper
• Novel signal transduction pathway mediating endothelium‐dependent β‐adrenoceptor vasorelaxation in rat thoracic aorta

  1992cited by this paper
• Attenuated responses to endothelin‐1, KCl and CaCl2, but not noradrenaline, of aortae from rats with streptozotocin‐induced diabetes mellitus

  1991cited by this paper
• Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase

  1991cited by this paper
• Nitric oxide synthase inhibitors inhibit interleukin-1 beta-induced depression of vascular smooth muscle.

  1991cited by this paper
• l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro

  1990cited by this paper
• Enhanced Contractile Responses of Arteries from Diabetic Rats to α1‐Adrenoceptor Stimulation in the Absence and Presence of Extracellular Calcium

  1990cited by this paper
• Effects of ponalrestat on depressor responses to arachidonic acid in streptozotocin-diabetic rats.

  1990cited by this paper
• Muscle length, shortening, myoplasmic [Ca2+], and activation of arterial smooth muscle.

  1990cited by this paper
• Mechanoreception by the endothelium: mediators and mechanisms of pressure- and flow-induced vascular responses.

  1990cited by this paper
• Characterization of DOI, a putative 5-HT2 receptor agonist in the rat.

  1989cited by this paper
• Effects of experimental diabetes on the responsiveness of rat aorta

  1989cited by this paper
• Endothelium-derived relaxing factor.

  1989cited by this paper
• The threshold concentration of dietary ethanol necessary to produce toxic effects on hippocampal cells and synapses in the mouse.

  1989cited by this paper
• DOI is a mixed agonist-antagonist at postjunctional 5-HT2 receptors in the pithed rat.

  1989cited by this paper
• 5-HT1B and 5-HT2 serotonin binding sites in cultured Wistar-Kyoto rat aortic smooth muscle cells.

  1989cited by this paper
• Effects of streptozotocin-induced hyperglycemia on agonist-stimulated phosphatidylinositol turnover in rat aorta.

  1989cited by this paper
• Molecular pharmacology and biology of 5-HT1C receptors.

  1988cited by this paper
• Influence of the endothelium on contractile responses of arteries from diabetic rats.

  1988cited by this paper
• Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers?

  1987cited by this paper
• A Contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit

  1987cited by this paper
• Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.

  1986cited by this paper
• Experimental diabetes: reduction of serotonin-induced vasoconstriction by meclofenamic acid in vitro.

  1985cited by this paper
• Injury of arterial endothelial cells in diabetic, sucrose-fed and aged rats.

  1984cited by this paper
• Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover.

  1984cited by this paper
• Increased alpha 2-adrenoreceptor mediated vascular contraction in diabetic rats.

  1983cited by this paper
• Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle.

  1981cited by this paper
• Vascular disease in diabetes: pathophysiological mechanisms and therapy.

  1979cited by this paper
• The active tension-length curve of vascular smooth muscle related to its cellular components

  1979cited by this paper
• Alteration in vascular smooth muscle sensitivity to vasoconstrictor agents by streptozotocin induced diabetes.

  1979cited by this paper
• Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

  1977cited by this paper
• Length‐Tension Relationship of Smooth Muscle of the Hog Carotid Artery

  1973cited by this paper

• The Cyclooxygenase and Nitric Oxide Synthesis/Pathways Mediate the Inhibitory Serotonergic Response to the Pressor Effect Elicited by Sympathetic Stimulation in Long-Term Diabetic Pithed Rats

  2012cites this paper
• Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats.

  2011cites this paper
• Contractility of Diabetic Human Corpus Cavernosum Smooth Muscle in Response to Serotonin Mediated via Rho-Kinase

  2009cites this paper
• INCREASED SUPEROXIDE CONTRIBUTES TO ENHANCEMENT OF VASCULAR CONTRACTION IN INS2AKITA DIABETIC MICE, AN AUTOSOMAL DOMINANT MUTANT MODEL

  2008cites this paper
• The in vitro vascular effects of two chirodropid (Chironex fleckeri and Chiropsella bronzie) venoms.

  2007cites this paper
• Influencia de la diabetes experimental sobre la reactividad de las arterias basilar, carótida y renal de conejo a la endotelina-1.

  2006cites this paper
• Atherosclerosis, Hypertension and Diabetes

  2003cites this paper
• The effects of 5-hydroxytryptamine 5-HT2 receptor antagonists on nerve conduction velocity and endoneurial perfusion in diabetic rats

  2003cites this paper
• The role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation

  2003cites this paper
• Usefulness of 5-Ht2a Receptor Antagonists for The Treatment of Cardiovascular Complications in Diabetes

  2003cites this paper
• Role of endogenous reactive oxygen derived species and cyclooxygenase mediators in 5-hydroxytryptamine-induced contractions in rat aorta: relationship to nitric oxide.

  2002cites this paper
• Impact of serotonin on tumour growth

  2000cites this paper
• Role of endothelial factors in the specific response of mouse tumour-feeding arterioles to stimulation of 5-HT1 receptors.

  1999cites this paper
• Influences of endothelium on the time course of noradrenaline-, 5-HT-, prostaglandin F2alpha- and high-K+-induced contractions in aortae of WKY and SHRSP.

  1998cites this paper
• Profile of neurohumoral agents on mesenteric and intestinal blood flow in health and disease.

  1998cites this paper
• Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction.

  1998cites this paper
• A role for protein kinase C in the attenuated response to 5-hydroxytryptamine in aortas from streptozotocin-diabetic rats.

  1997cites this paper
• Effects of experimental diabetes and insulin on smooth muscle functions.

  1996cites this paper
• Cardiovascular Adverse Reactions to Sumatriptan

  1995cites this paper
• Potentiation by endothelin‐1 of 5‐hydroxytryptamine responses in aortae from streptozotocin‐diabetic rats: a role for thromboxane A2

  1995cites this paper
• Enhanced 5-HT2 receptor mediated contractions in diabetic rat aorta: participation of Ca2+ channels associated with protein kinase C activity.

  1995cites this paper
• Attenuated 5-HT2 receptor-mediated responses in hindquarters of diabetic rats.

  1995cites this paper
• Attenuated 5‐hydroxytryptamine receptor‐mediated responses in aortae from streptozotocin‐induced diabetic rats

  1994cites this paper
• Effects of haemoglobin and N-nitro-L-arginine on constrictor and dilator responses of aortic rings from streptozotocin diabetic rats.

  1993cites this paper